プレスリリース

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

  • 43rd Annual Cowen Health Care Conference on March 7, 2023
    Fireside chat at 6:50am Pacific Time (9:50am Eastern Time)

The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.  A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com

Media:
David McAlpine
+1.347.327.1336
pr@illumina.com

 

Cision View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301757041.html

SOURCE Illumina, Inc.

最近の記事

イルミナとOIST、日本におけるゲノミクス イノベーションの加速を目的とした覚書を締結
イルミナとOIST、日本におけるゲノミクス イノベーションの加速を目的とした覚書を締結
希少疾患コミュニティは、診断から治癒まで、プレシジョンメディシンのために戦っています
希少疾患コミュニティは、診断から治癒まで、プレシジョンメディシンのために戦っています
Admera Health uses the NovaSeq X Plus to expand capabilities
Admera Health uses the NovaSeq X Plus to expand capabilities